| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 225 | 225 | 225 |
| Full Text Views | 3 | 3 | 3 |
| PDF Downloads | 4 | 4 | 4 |
Seroprevalence and Distribution of Toxoplasma gondii Infections among Patients in the West Bank, Palestine (2017–2021)
Rania Abu Seir
Rania Abu Seir
Faculty of Health Professions, Al-Quds University, Abu Dis, Palestine;
Search for other papers by Rania Abu Seir in
Current site
Google Scholar
PubMed
Search for other papers by Rania Abu Seir in
Current site
Google Scholar
PubMed
Jerzy M. Behnke
Jerzy M. Behnke
School of Life Sciences, University of Nottingham, Nottingham, United Kingdom;
Search for other papers by Jerzy M. Behnke in
Current site
Google Scholar
PubMed
Search for other papers by Jerzy M. Behnke in
Current site
Google Scholar
PubMed
Marawan Abu-Madi
Marawan Abu-Madi
Department of Biomedical Science, College of Health Sciences, Qatar University, Doha, Qatar
Search for other papers by Marawan Abu-Madi in
Current site
Google Scholar
PubMed
Search for other papers by Marawan Abu-Madi in
Current site
Google Scholar
PubMed
Toxoplasmosis is a zoonotic disease caused by the obligate intracellular protozoan Toxoplasma gondii. The current study assessed the seroepidemiological status and risk factors of T. gondii in the West Bank, Palestine. We conducted a retrospective study among 1,475 patients referred for serological examination for toxoplasmosis between 2017 and 2021 at the Central Public Health Laboratory. The overall prevalences of anti–T. gondii IgG and IgM antibodies were 1.0% [18.9–23.0%] and 1.0% [0.5–1.6%], respectively. Multifactorial analysis showed that age and sex were significantly associated with the presence of IgG antibodies. The prevalence of IgG antibodies was highest in 2018 and decreased significantly each year until 2021. Routine serological screening in women of childbearing age and pregnant women is recommended.
Author Notes
Disclosure: The study was approved by the Research Ethical Committee (REC) at Al-Quds University, Palestine (reference number 260/REC/2022). Considering the retrospective nature of the study and all the procedures being performed as part of routine care and because the retrieved data were anonymized to maintain the confidentiality of patients, individual informed consent was waived by the REC.
Current contact information: Rania Abu Seir, Faculty of Health Professions, Al-Quds University, Abu Dis, Palestine, E-mail: rabusear@staff.alquds.edu. Jerzy M. Behnke, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom, E-mail: jerzy.behnke@nottingham.ac.uk. Marawan Abu-Madi, Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, Doha, Qatar, E-mail: abumadi@qu.edu.qa.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 225 | 225 | 225 |
| Full Text Views | 3 | 3 | 3 |
| PDF Downloads | 4 | 4 | 4 |